COPD patients experienced benefits from the first dose when treated with aclidinium, as shown in the ATTAIN Phase III study

· Aclidinium demonstrates improved lung function, symptom control and quality of life for Chronic Obstructive Pulmonary Disease ( COPD) patients

The release as fetched from its publisher. almirall.com ↗